developmentstoday

Ask DT AI Audio Brief Videos Podcast +

Ask DT AI Audio Brief Videos Podcast

HomeTagsdepression

#depression

All articles tagged with "depression"

Company

About Us
Advertise
Contact
Editorial Policy

Legal

Terms of Service
Privacy Policy
Cookie Policy
AI & Ethics Policy
Do Not Sell My Info
FAQ
Site Map

Discover

Newsletter
Ask DT AI
Audio Brief
Videos
Podcast
DT Premium

Connect

Twitter / X
Facebook
LinkedIn
YouTube
Instagram
TikTok
Flipboard
RSS Feed

© 2026 Developments Today. All rights reserved.

depression Articles | Developments Today

Parkinson's medication shows promise in treating treatment-resistant depression

Parkinson’s drug shows promise for resistant depression

A nine-week trial tested pramipexole as an add-on therapy for treatment-resistant depression with marked anhedonia.
Patients receiving pramipexole improved more than the placebo group.
Brain imaging suggested effects on reward-related ventral striatal activity.

DE

DT Editorial Team·Jun 12, 2026·via medicalxpress.com

More in Health→

GLP-1s may alleviate depression through the microbiome, mouse study suggests

GLP-1 Drugs May Ease Depression via Gut Microbiome, Mouse Study Finds

Liraglutide accumulated in the intestine, not the brain, in stressed mice.
Antidepressant effects persisted in mice with GLP-1 receptors knocked out.
Depleting gut microbiota with antibiotics eliminated the antidepressant effect.
Lactobacillus delbrueckii increased significantly and produces a precursor to the endocannabinoid 2-AG.

DE

DT Editorial Team·Jun 10, 2026·via medicalxpress.com

More in Health→

Mental health disorders become top global disability cause as cases near 1.2 billion

Mental health disorders become the world’s leading disability burden

A global analysis found nearly 1.2 billion people lived with a mental health disorder in 2023.
Researchers said mental health disorders are now the leading cause of disability worldwide.
Major depressive disorder and anxiety disorders both rose sharply after 2019.
The burden peaks among people aged 15 to 19 and disproportionately affects women.

DE

DT Editorial Team·Jun 1, 2026·via medicalxpress.com

More in Health→

A single dose of psilocybin eased depression symptoms for months, our study found

Psilocybin Showed Fast Antidepressant Effects in a Small Trial, but Blinding Remains a Major Problem

A randomized trial found that psilocybin reduced depression symptoms within days and outperformed placebo over the short term.
More than half of the psilocybin group no longer met depression criteria after six weeks, versus one person in the placebo group.
Most participants correctly guessed which treatment they received, highlighting a major methodological issue in psychedelic research.

DE

DT Editorial Team·May 22, 2026·via medicalxpress.com

More in Health→

Mental disorders have nearly doubled since 1990, now affecting 1.2 billion people worldwide

Mental Disorders Now Rank as the World’s Leading Cause of Disability

A global study found nearly 1.2 billion people were living with a mental disorder in 2023.
Mental disorders now account for the largest share of disability worldwide.
Anxiety and major depressive disorder have risen sharply since 2019.
Adolescents aged 15 to 19 and women are disproportionately affected.

DE

DT Editorial Team·May 22, 2026·via medicalxpress.com

DE

DT Editorial Team·May 20, 2026·via gizmodo.com

DE

DT Editorial Team·May 20, 2026·via medicalxpress.com

DE

DT Editorial Team·May 14, 2026·via medicalxpress.com

DE

DT Editorial Team·May 10, 2026·via medicalxpress.com

DE

DT Editorial Team·May 4, 2026·via medicalxpress.com

DE

DT Editorial Team·May 1, 2026·via medicalxpress.com

DE

DT Editorial Team·Apr 27, 2026·via medicalxpress.com

DE

DT Editorial Team·Apr 25, 2026·via sciencedaily.com

DE

DT Editorial Team·Apr 25, 2026·via medicalxpress.com

DE

DT Editorial Team·Apr 14, 2026·via medicalxpress.com

More in Health→

This 3-Minute Video Game Is Surprisingly Good at Spotting Depression

A Three-Minute Smartphone Game Could Become a New Screen for Depression

NYU researchers created a three-minute game to detect anhedonia, a common feature of depression.
Players with major depression switched away from declining rewards earlier than healthy controls.
The team says game behavior also tracked with illness severity and is pursuing FDA clearance.

More in Culture→

Pilot trial points to immune-targeted therapy for hard-to-treat depression

A 30-person pilot trial tested tocilizumab in moderate-to-severe depression that had not responded to standard antidepressants.
Compared with placebo, the anti-inflammatory drug appeared to reduce depression symptoms and improve fatigue, anxiety, and quality of life.
The study adds clinical support to the idea that an IL-6-linked inflammatory pathway may drive a subset of depression cases.

More in Health→

Semaglutide study links diabetes drug to improved motivation in major depressive disorder

A study published in JAMA Psychiatry found semaglutide significantly improved measures of motivation in patients with major depressive disorder.
The reported effect focuses on motivation, a clinically important symptom domain in depression.
The supplied source does not provide trial size, effect size, or treatment protocol details, so the finding remains an early but notable signal.

More in Health→

Existing drug combinations show new promise for treatment-resistant depression

Researchers reviewed 26 randomized controlled trials of intravenous ketamine.
Ketamine outperformed placebo over the short term and appeared comparable to esketamine.
Both ketamine and esketamine were reported to rapidly reduce suicidal impulses in acute cases.

More in Health→

A Blood-Aging Signal May Help Explain Why Depression Does Not Look the Same in Everyone

Researchers linked a blood-based aging signal to cognitive and mood-related depression symptoms.
The finding was highlighted in work involving women with HIV, who face elevated depression risk.
The result points toward more specific biomarkers rather than a single universal depression test.

More in Health→

Researchers Trace Ketamine’s Fast Antidepressant Effects to a Specific Brain Circuit

Researchers published the study in Cell.
The work links ketamine’s effects to specific opioid receptors on prefrontal cortex interneurons.
The finding may support development of rapid-acting antidepressants with fewer side effects.
Ketamine remains clinically useful but limited by short-lived effects and safety concerns.

More in Health→

New Algorithm Aims to Flag Self-Harm Risk Before Clear Warning Signs Emerge

A new algorithm is designed to identify people who may be headed for self-harm before warning signs are obvious.
The report frames the work in the context of depression, a widespread mental health disorder.
The main promise is earlier intervention, though the supplied material does not provide technical performance details.

More in Health→

Harvard scientists link gut bacteria to depression through hidden inflammation trigger

Harvard Researchers Trace a Possible Gut-to-Depression Path Through an Inflammation Trigger

Researchers identified a mechanism involving Morganella morganii and the contaminant DEA.
The altered bacterial molecule triggers immune activity and inflammatory cytokines.
The findings may open paths to diagnosis or treatment that target immune pathways.

More in Science→

Psilocybin is moving deeper into depression research, but the evidence still comes with limits

Researchers reviewed 15 clinical trials testing psilocybin for depression.
The analysis was published in Nature Mental Health.
The review strengthens the case for continued study while emphasizing methodological limits.
Interest is being driven in part by patients who do not benefit enough from standard treatments.

More in Health→

AI-Driven Depression Screening Pushes Beyond Checkboxes

Researchers tested an AI approach that lets people describe depressive symptoms in natural language.
The study says the method improved both screening accuracy and user experience.
The work challenges the long dominance of standardized rating scales in psychological assessment.

More in Health→